Analysis of morpho-functional parameters of the heart and polymorphisms of renin-angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy

Kardiologiya

Volumn 50, Issue 6, 2010, Pages 27-34

  Belenkov, Yu N ^a   Privalova, E V ^a   Kaplunova, V Yu ^a   Stambolsky, D V ^a   Fomin, A A ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Clinical variants of disease course; Genes modifiers; Genetic polymorphism; Hypertrophic cardiomyopathy; Renin angiotensin aldosterone system

Indexed keywords

AGT PROTEIN, HUMAN; AGTR1 PROTEIN, HUMAN; ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CHYMASE; CMA1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; DISEASE COURSE; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEART; HEART MUSCLE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOLECULAR DIAGNOSIS; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ALDOSTERONE SYNTHASE; ALLELES; ANGIOTENSINOGEN; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CHYMASES; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MYOCARDIUM; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 79952114154     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Contemporary definitions and classification of the cardiomyopathies. Circulation 2006; 113:1807-1816.
2. Maron B.J., Casey S.A., Mauser R.G. et al. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol 2003; 42:882-888. (Pubitemid 37069223)
3. Maron B. J., Olivolto I., Splrito P. et al. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation 2000; 102:858-864.
4. Elliott P., Spirito P. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart 2008; 94:1269-2175.
5. Maron B.J., McKenna WJ, Danlelson G.K. et al. American College of Cardiology/ European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. J Am Coll Cardiol 2003; 42:1587-1713.
6. Kojflard M.J., Cate F.J. et al. Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. Am Coll Cardiol 2003; 41:987-993. (Pubitemid 36315542)
7. Ramara J.R. Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment. Cardiol Rev 2008; 16:172-180.
8. Fatkln D., Graham R.M. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 2002; 82:945-980.
9. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001; 104:557-567. (Pubitemid 32201950)
10. Keren A., Syrrls P., McKenna W.J. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 2008, 5:158-168.
11. Patel R., Urn D.S., Reddy D. et al. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. J Mol and Cel Cardiol 2000; 32:2369-2377. (Pubitemid 32039786)
12. Soor G.S., Luk A., Ann E. et al. Hypertrophic cardiomyopathy: current understanding and treatment objectives. J Clin Pathol 2009; 62:226-235.
13. Lechin M., Quinones M.A., Marlan A.J. et al. Angiotensin- convertingenzymegenotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92:1808-1812.
14. Pfeufer A., Osterzlel K.J., Urata H. et al. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy. Am J Cardiol 1996; 78:362-364. (Pubitemid 26265286)
15. Osterop A., Kofflard M., Sandkuijl L. et al. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophic cardiomyopathy. Hypertension 1998; 32:825-830.
16. Jshanov A., Okamoto H., Yoneya K. et al. Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am. Heart J. 1997; 133:184-189.
17. Kupari M., Hautanen A., Lanktnen L. et al. Associations between human aldosterone synthase (CYPUB2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998; 97:569-575. (Pubitemid 28090686)
18. Charron P., Dubourg O., Desnos M. et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997; 96:214-219. (Pubitemid 27298423)
19. Cecchi F., Montereggl A., Olivolto I. et al. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal-averaged P-wave. Heart 1997; 78:44-49. (Pubitemid 27346880)
20. Maron M.S., Olivotto I., Betoccki S. et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348:295-303. (Pubitemid 36119984)
21. Panza J.A., Maron B.J. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol 1989; 63:1258-1265. (Pubitemid 19130264)
22. Dot Y., Kilaoka H. Hypertrophic cardiomyopathy in the elderly: Significance of atrial fibrillation. Cardiol 2001; 37:133-138.
23. Reamers J., Conde L., Medina I. et al. Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNP effect and Pupa Suite databases. Nucl Acids Res 2008; 36, Database issue.
24. Morlmoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 2008; 77:659-666.
25. Ortlepp J.R., Vosberg H.P., Relth S. et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 2002; 87:270-275. (Pubitemid 34177686)